[Lupic spinal cord diseases and antiphospholipid antibodies]

Rev Neurol (Paris). 1997 Mar;153(2):138-40.
[Article in French]

Abstract

Central nervous system involvement in systemic lupus erythematosus (SLE) is frequent and severe, however, myelopathy is rarely reported (0.8 p. 100 of SLE cases). We describe two SLE-young women. They were 21 and 37 year old, presented with acute paraplegia. CSF study showed pleocytosis and moderately elevated protein. Antinuclear, anti-DNA and anticardiolipin were positive. High dose steroids therapy induced marked improvement. The pathogenesis of myelopathy in SLE remains unclear. Anti-phospholipid antibodies may cause thrombosis and ischemic myelopathy. However, auto-antibodies directed against central nervous system constituents may be involved.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Antibodies, Antiphospholipid / analysis*
  • Antibodies, Antiphospholipid / physiology
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / immunology
  • Methylprednisolone / therapeutic use
  • Prednisone / therapeutic use
  • Prognosis
  • Spinal Cord Diseases / drug therapy
  • Spinal Cord Diseases / etiology*
  • Spinal Cord Diseases / immunology

Substances

  • Antibodies, Antiphospholipid
  • Glucocorticoids
  • Prednisone
  • Methylprednisolone